細胞・遺伝子治療臨床試験サービスの世界市場レポート 2024年

細胞・遺伝子治療臨床試験サービスの市場規模は、今後数年で急成長が見込まれます。2028年にはCAGR10.4％で56億4,000万米ドルに成長します。予測期間中に予想される成長は、遺伝性疾患や自己免疫疾患の世界の罹患率の増加、遺伝子治療研究に対する官民両部門からの資金提供の増加、新規技術の採用拡大、同定された遺伝子異常の数の増加など、いくつかの要因に起因しています。この期間に予想される主な動向には、人工知能（AI）と機械学習の採用、個別化医療の統合、技術の進歩、遺伝子治療の開発などがあります。

遺伝性疾患の有病率の増加は、今後の細胞・遺伝子治療臨床試験サービス市場の拡大を促進すると予想されます。遺伝性疾患は、個人のDNAや遺伝的構造の変異に起因するものであり、遺伝子検査へのアクセスの向上、遺伝子変異の発生、近親婚の普及などの要因により、より一般的になりつつあります。細胞・遺伝子治療臨床試験サービスは、革新的な治療法の開発を促進し、個々の患者のために治療法をカスタマイズし、研究の臨床応用への転換を加速し、遺伝性疾患患者が利用できる治療法の選択肢を広げることによって、増加する遺伝性疾患の発生率に対処する上で重要な役割を果たしています。例えば、嚢胞性線維症（CF）財団の2022年7月の報告書によると、嚢胞性線維症と診断される患者数は顕著に増加しており、米国だけでも約4万人の子供と成人が罹患しています。その結果、遺伝性疾患の有病率の上昇が細胞・遺伝子治療臨床試験サービス市場成長の主要促進要因となっています。

細胞・遺伝子治療臨床試験サービス市場の主要企業は、業務効率を高め、競争上の優位性を獲得するために、顧客関係管理（CRM）システム技術などの先進技術の導入に力を注いでいます。細胞・遺伝子治療臨床試験サービスが活用するCRMシステムは、臨床試験のプロセスを通じて、臨床試験参加者やヘルスケアプロバイダー、その他の利害関係者とのやり取りを合理化・管理します。例えば、2023年 4月、AmerisourceBergen Corporationは、細胞・遺伝子治療パスウェイ全体の接続性を強化し、プロセスを合理化するために設計されたプラットフォーム、Cell and Gene Therapy（CGT）Integration Hubを発表しました。アメリソース・バーゲンのCRMシステムによってサポートされるこのプラットフォームは、医師と患者サービスチームが治療法の開発と提供のプロセス全体をよりよく把握できるようにすることで、ケアコーディネーションを簡素化することを目的としています。CGT Integration Hubには、迅速な給付金調査、リアルタイムのステータス追跡、プロアクティブアラートなどの機能が含まれており、これらはすべて、ケアコーディネーションを簡素化し、細胞および遺伝子治療の提供における患者と医療提供者の全体的な経験を向上させることを目的としています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の市場規模と成長

• 世界の細胞・遺伝子治療臨床試験サービス市場：促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の細胞・遺伝子治療臨床試験サービス市場の実績：規模と成長, 2018-2023
• 世界の細胞・遺伝子治療臨床試験サービス市場の予測：規模と成長, 2023-2028, 2033F

第6章 市場セグメンテーション

• 世界の細胞・遺伝子治療臨床試験サービス市場：サービス別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 臨床試験の設計と計画
• 供給および物流サービス
• 規制関連業務およびコンプライアンス
• データ管理と生物統計学
• サイトの管理と監視
• 他のサービス
• 世界の細胞・遺伝子治療臨床試験サービス市場：治療タイプ別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 遺伝子治療
• 細胞療法
• 遺伝子組み換え細胞療法
• 世界の細胞・遺伝子治療臨床試験サービス市場：適応症別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 腫瘍学
• 血液学
• 代謝障害
• 感染症
• 神経学
• 心血管疾患
• 筋骨格障害
• その他の適応症
• 世界の細胞・遺伝子治療臨床試験サービス市場：最終用途別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 製薬およびバイオテクノロジー企業
• 契約研究機関
• 学術研究機関
• その他のエンドユーザー

第7章 地域別・国別分析

• 世界の細胞・遺伝子治療臨床試験サービス市場：地域別、実績と予測, 2018-2023, 2023-2028F, 2033F
• 世界の細胞・遺伝子治療臨床試験サービス市場：国別、実績と予測, 2018-2023, 2023-2028F, 2033F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 細胞・遺伝子治療臨床試験サービス市場：競合情勢
• 細胞・遺伝子治療臨床試験サービス市場：企業プロファイル
  • Thermo Fisher Scientific Inc.
  • Sharp Services LLC
  • IQVIA
  • Laboratory Corporation of America Holdings
  • ICON plc

第31章 その他の大手企業と革新的企業

• Syneos Health Inc.
• Catalent Pharma Solutions Inc.
• Charles River Laboratories International Inc.
• Parexel International Corporation
• PRA Health Sciences Inc.
• Covance Inc.
• Medpace Holdings Inc.
• BioClinica Inc.
• Precision Medicine Group LLC
• Worldwide Clinical Trials LLC
• Clinigen Group plc
• Evidera Inc.
• Advarra LLC
• Veristat LLC
• Clinipace Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

Cell and gene therapy clinical trial services are specialized offerings provided by contract research organizations (CROs) or clinical trial management firms to support the design, implementation, and oversight of clinical trials for cell and gene therapies. These services encompass various aspects such as protocol design, patient recruitment, regulatory compliance, and data management, ensuring precision, efficacy, and adherence to rigorous standards throughout the trial process.

The primary types of cell and gene therapy clinical trial services include clinical trial design and planning, supply chain and logistics management, regulatory affairs and compliance, data management and biostatistics, site management and monitoring, among others. Clinical trial design and planning entail the development and organization of trial protocols, determining the objectives and methodologies of the trial. Various types of therapies, including gene therapy, cell therapy, and gene-modified cell therapy, are utilized for a range of indications such as oncology, hematology, metabolic disorders, infectious diseases, neurology, cardiovascular diseases, musculoskeletal disorders, among others. These services cater to a diverse range of end-users, including pharmaceutical and biotechnology companies, contract research organizations, academic and research institutions, among others.

The cell and gene therapy clinical trial services market research report is one of a series of new reports from The Business Research Company that provides cell and gene therapy clinical trial services market statistics, including cell and gene therapy clinical trial services industry global market size, regional shares, competitors with a cell and gene therapy clinical trial services market share, detailed cell and gene therapy clinical trial services market segments, market trends and opportunities, and any further data you may need to thrive in the cell and gene therapy clinical trial services industry. This cell and gene therapy clinical trial services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell and gene therapy clinical trial services market size has grown rapidly in recent years. It will grow from $3.44 billion in 2023 to $3.79 billion in 2024 at a compound annual growth rate (CAGR) of 10.2%. The growth observed during the historic period can be attributed to several factors, including the heightened prevalence of chronic diseases, growing demand for effective treatments targeting rare genetic disorders, increased government funding allocated to research in regenerative medicine, enhanced understanding of molecular mechanisms associated with various diseases, and heightened awareness regarding the potential benefits of personalized medicine.

The cell and gene therapy clinical trial services market size is expected to see rapid growth in the next few years. It will grow to $5.64 billion in 2028 at a compound annual growth rate (CAGR) of 10.4%. The anticipated growth in the forecast period can be attributed to several factors, including the increasing global incidence of genetic and autoimmune diseases, rising funding from both public and private sectors for gene therapy research, growing adoption of novel technologies, and an increase in the number of genetic defects identified. Major trends expected during this period include the adoption of Artificial Intelligence (AI) and machine learning, the integration of personalized medicine, advancements in technology, and the development of gene therapies.

The increasing prevalence of genetic diseases is expected to drive the expansion of the cell and gene therapy clinical trial services market in the future. Genetic diseases result from variations in an individual's DNA or genetic makeup and are becoming more common due to factors such as increased accessibility to genetic testing, occurrences of genetic mutations, and the prevalence of consanguineous marriages. Cell and gene therapy clinical trial services play a crucial role in addressing the growing incidence of genetic diseases by fostering the development of innovative treatments, customizing therapies for individual patients, accelerating the translation of research into clinical applications, and broadening the treatment options available to patients with genetic disorders. For instance, according to the Cystic Fibrosis (CF) Foundation's July 2022 report, there has been a notable increase in the number of individuals diagnosed with cystic fibrosis, affecting nearly 40,000 children and adults in the United States alone, and over 105,000 people worldwide. Consequently, the rising prevalence of genetic diseases is a key driver behind the growth of the cell and gene therapy clinical trial services market.

Leading companies in the cell and gene therapy clinical trial services market are concentrating their efforts on introducing advanced technology, including customer relationship management (CRM) system technology, to enhance operational efficiency and gain a competitive advantage. CRM systems utilized by cell and gene therapy clinical trial services streamline and manage interactions with trial participants, healthcare providers, and other stakeholders throughout the clinical trial process. For instance, in April 2023, AmerisourceBergen Corporation unveiled the Cell and Gene Therapy (CGT) Integration Hub, a platform designed to enhance connectivity and streamline processes across the cell and gene therapy treatment pathway. Supported by AmerisourceBergen's CRM system, this platform aims to simplify care coordination by providing physicians and patient services teams with better visibility throughout the therapy development and delivery process. The CGT Integration Hub includes features such as expedited benefits investigation, real-time status tracking, and proactive alerts, all aimed at simplifying care coordination and improving the overall patient and provider experience in delivering cell and gene therapies.

In January 2024, Kyowa Kirin Co. Ltd. acquired Orchard Therapeutics Limited to strengthen its focus on addressing unmet medical needs in genetic and severe diseases by leveraging Orchard's expertise in developing and commercializing gene therapies for rare diseases. Orchard Therapeutics Limited, a UK-based biotechnology company, is dedicated to researching, developing, and commercializing gene therapies for rare diseases.

Major companies operating in the cell and gene therapy clinical trial services market are Thermo Fisher Scientific Inc., Sharp Services LLC, IQVIA, Laboratory Corporation of America Holdings, ICON plc, Syneos Health Inc., Catalent Pharma Solutions Inc., Charles River Laboratories International Inc., Parexel International Corporation, PRA Health Sciences Inc., Covance Inc., Medpace Holdings Inc., BioClinica Inc., Precision Medicine Group LLC, Worldwide Clinical Trials LLC, Clinigen Group plc, Evidera Inc., Advarra LLC, Veristat LLC, Clinipace Inc., Celonic AG, Cromsource Inc., Novotech Pty Ltd., MedSource Holdings Inc., Frontage Laboratories Inc.

North America was the largest region in the cell and gene therapy clinical trial services market in 2023. It is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy clinical trial services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell and gene therapy clinical trial services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell and gene therapy clinical trial services market includes revenues earned by providing services, such as regulatory pathways navigation, logistics management, patient retention strategy management, and biomarker analysis services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell And Gene Therapy Clinical Trial Services Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell and gene therapy clinical trial services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell and gene therapy clinical trial services? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell and gene therapy clinical trial services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Service: Clinical Trial Design And Planning; Supply And Logistic Services; Regulatory Affairs And Compliance; Data Management And Biostatics; Site Management And Monitoring; Other Services
• 2) By Therapy Type: Gene Therapy; Cell Therapy; Gene Modified Cell Therapy
• 3) By Indication: Oncology; Hematology; Metabolic Disorders; Infectious Diseases; Neurology; Cardiovascular Diseases; Musculoskeletal Disorders; Other Indications
• 4) By End-Use: Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Academic And Research Institutes; Other End-Users
• Companies Mentioned: Thermo Fisher Scientific Inc.; Sharp Services LLC; IQVIA; Laboratory Corporation of America Holdings; ICON plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cell And Gene Therapy Clinical Trial Services Market Characteristics

3. Cell And Gene Therapy Clinical Trial Services Market Trends And Strategies

4. Cell And Gene Therapy Clinical Trial Services Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Cell And Gene Therapy Clinical Trial Services Market Size and Growth

• 5.1. Global Cell And Gene Therapy Clinical Trial Services Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Cell And Gene Therapy Clinical Trial Services Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Cell And Gene Therapy Clinical Trial Services Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cell And Gene Therapy Clinical Trial Services Market Segmentation

• 6.1. Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Clinical Trial Design And Planning
• Supply And Logistic Services
• Regulatory Affairs And Compliance
• Data Management And Biostatics
• Site Management And Monitoring
• Other Services
• 6.2. Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Gene Therapy
• Cell Therapy
• Gene Modified Cell Therapy
• 6.3. Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oncology
• Hematology
• Metabolic Disorders
• Infectious Diseases
• Neurology
• Cardiovascular Diseases
• Musculoskeletal Disorders
• Other Indications
• 6.4. Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Pharmaceutical And Biotechnology Companies
• Contract Research Organizations
• Academic And Research Institutes
• Other End-Users

7. Cell And Gene Therapy Clinical Trial Services Market Regional And Country Analysis

• 7.1. Global Cell And Gene Therapy Clinical Trial Services Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Cell And Gene Therapy Clinical Trial Services Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cell And Gene Therapy Clinical Trial Services Market

• 8.1. Asia-Pacific Cell And Gene Therapy Clinical Trial Services Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cell And Gene Therapy Clinical Trial Services Market

• 9.1. China Cell And Gene Therapy Clinical Trial Services Market Overview
• 9.2. China Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cell And Gene Therapy Clinical Trial Services Market

• 10.1. India Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cell And Gene Therapy Clinical Trial Services Market

• 11.1. Japan Cell And Gene Therapy Clinical Trial Services Market Overview
• 11.2. Japan Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cell And Gene Therapy Clinical Trial Services Market

• 12.1. Australia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cell And Gene Therapy Clinical Trial Services Market

• 13.1. Indonesia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cell And Gene Therapy Clinical Trial Services Market

• 14.1. South Korea Cell And Gene Therapy Clinical Trial Services Market Overview
• 14.2. South Korea Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cell And Gene Therapy Clinical Trial Services Market

• 15.1. Western Europe Cell And Gene Therapy Clinical Trial Services Market Overview
• 15.2. Western Europe Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cell And Gene Therapy Clinical Trial Services Market

• 16.1. UK Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cell And Gene Therapy Clinical Trial Services Market

• 17.1. Germany Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cell And Gene Therapy Clinical Trial Services Market

• 18.1. France Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cell And Gene Therapy Clinical Trial Services Market

• 19.1. Italy Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cell And Gene Therapy Clinical Trial Services Market

• 20.1. Spain Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cell And Gene Therapy Clinical Trial Services Market

• 21.1. Eastern Europe Cell And Gene Therapy Clinical Trial Services Market Overview
• 21.2. Eastern Europe Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cell And Gene Therapy Clinical Trial Services Market

• 22.1. Russia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cell And Gene Therapy Clinical Trial Services Market

• 23.1. North America Cell And Gene Therapy Clinical Trial Services Market Overview
• 23.2. North America Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cell And Gene Therapy Clinical Trial Services Market

• 24.1. USA Cell And Gene Therapy Clinical Trial Services Market Overview
• 24.2. USA Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cell And Gene Therapy Clinical Trial Services Market

• 25.1. Canada Cell And Gene Therapy Clinical Trial Services Market Overview
• 25.2. Canada Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cell And Gene Therapy Clinical Trial Services Market

• 26.1. South America Cell And Gene Therapy Clinical Trial Services Market Overview
• 26.2. South America Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cell And Gene Therapy Clinical Trial Services Market

• 27.1. Brazil Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cell And Gene Therapy Clinical Trial Services Market

• 28.1. Middle East Cell And Gene Therapy Clinical Trial Services Market Overview
• 28.2. Middle East Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cell And Gene Therapy Clinical Trial Services Market

• 29.1. Africa Cell And Gene Therapy Clinical Trial Services Market Overview
• 29.2. Africa Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cell And Gene Therapy Clinical Trial Services Market Competitive Landscape And Company Profiles

• 30.1. Cell And Gene Therapy Clinical Trial Services Market Competitive Landscape
• 30.2. Cell And Gene Therapy Clinical Trial Services Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Sharp Services LLC
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. IQVIA
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Laboratory Corporation of America Holdings
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. ICON plc
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Cell And Gene Therapy Clinical Trial Services Market Other Major And Innovative Companies

• 31.1. Syneos Health Inc.
• 31.2. Catalent Pharma Solutions Inc.
• 31.3. Charles River Laboratories International Inc.
• 31.4. Parexel International Corporation
• 31.5. PRA Health Sciences Inc.
• 31.6. Covance Inc.
• 31.7. Medpace Holdings Inc.
• 31.8. BioClinica Inc.
• 31.9. Precision Medicine Group LLC
• 31.10. Worldwide Clinical Trials LLC
• 31.11. Clinigen Group plc
• 31.12. Evidera Inc.
• 31.13. Advarra LLC
• 31.14. Veristat LLC
• 31.15. Clinipace Inc.

32. Global Cell And Gene Therapy Clinical Trial Services Market Competitive Benchmarking

33. Global Cell And Gene Therapy Clinical Trial Services Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Cell And Gene Therapy Clinical Trial Services Market

35. Cell And Gene Therapy Clinical Trial Services Market Future Outlook and Potential Analysis

• 35.1 Cell And Gene Therapy Clinical Trial Services Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Cell And Gene Therapy Clinical Trial Services Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Cell And Gene Therapy Clinical Trial Services Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer